Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: November 2022

MissionIRNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Releases Q3 2022 Financial Results, Corporate Updates

Posted on November 30, 2022 by MissionIR

BiondVax Pharmaceuticals (NASDAQ: BVXV), a biotech company that focuses on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, is reporting on its third quarter, the period ending Sept. 30, 2022; the report … Continue reading →

Posted in BiondVax Pharmaceuticals Ltd. BVXV | Leave a comment

MissionIRNewsBreaks – Correlate Infrastructure Partners Inc. (CIPI), EnerSys(R) (NYSE: ENS) Collaborate on One of the Largest Behind-the-Meter Solar Installation Projects

Posted on November 30, 2022 by MissionIR

Correlate Infrastructure Partners (OTCQB: CIPI), a technology-enabled energy optimization and clean energy solutions provider, today announced a solar energy installation project totaling 3.8 megawatts with EnerSys(R) (NYSE: ENS), the global leader in stored energy solutions, at its global headquarters in … Continue reading →

Posted in Correlate Infrastructure Partners Inc. CIPI | Leave a comment

MissionIRNewsBreaks – Vision Energy Corp. (VIHDD) Engages Rho Adviseurs for Green Energy Hub Project

Posted on November 30, 2022 by MissionIR

Vision Energy (OTCQB: VIHDD) today announced that it has engaged Rho Adviseurs, a Netherlands-based firm specializing in spatial planning and permit management, for the company’s pioneering Green Energy Hub development project in the North Sea Port of Vlissingen, the Netherlands. … Continue reading →

Posted in Vision Energy Corp. VIHDD | Leave a comment

MissionIRNewsBreaks – MICT Inc. (NASDAQ: MICT) Issues Update on Acquisition of Tingo Inc. (TMNA)

Posted on November 30, 2022 by MissionIR

MICT (NASDAQ: MICT) previously announced that it is scheduled to complete the acquisition of the operating business and assets of Tingo (OTC: TMNA) by Nov. 30, 2022. This will be achieved through the acquisition of 100% of Tingo’s sole operating … Continue reading →

Posted in Tingo Inc. TMNA | Leave a comment

MissionIRNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Forecasts Accelerated Growth in Coming Year

Posted on November 30, 2022 by MissionIR

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”), has announced its projected revenue growth for the next 12 months. The company has seen accelerated year-over-year growth, and with the increased interest as well as impressive upswing in … Continue reading →

Posted in Knightscope Inc. KSCP | Leave a comment

Data443 Risk Mitigation Inc. (ATDS) Is ‘One to Watch’

Posted on November 30, 2022 by MissionIR

Data443 Risk Mitigation (OTC: ATDS) is a data security and privacy software company for ALL THINGS DATA SECURITY(TM). The company is committed to organizing the world’s information by identifying and protecting all sensitive data regardless of location, platform or format. … Continue reading →

Posted in Data443 Risk Mitigation Inc. ATDS | Leave a comment

Cepton, Inc. (NASDAQ: CPTN) Launches ‘Periscope’ Lidar-Based Sensory System Designed to Increase Pedestrian Safety

Posted on November 30, 2022 by MissionIR

During the 1970s and 1980s, roadways across the U.S. and western Europe grew safer as the adoption of seatbelts, airbags, and improved vehicle designs became ubiquitous. At the time, the United States could credibly claim to be a global leader … Continue reading →

Posted in Cepton Inc. CPTN | Leave a comment

MissionIRNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH-CBD(TM) Demonstrates Enhanced Performance Compared to Leading Anti-Seizure Medication

Posted on November 29, 2022 by MissionIR

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that its patented DehydraTECH-CBD(TM) has demonstrated performance enhancements compared to one of the world’s leading anti-seizure medications, Epidiolex(R). According to the update, animal study program EPIL-A21-1 … Continue reading →

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

MissionIRNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Confirms Inhalation Concept of NanoAb as Therapy for COVID-19

Posted on November 29, 2022 by MissionIR

BiondVax (NASDAQ: BVXV) is a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases. The company today announced statistically significant (p<0.001) efficacy results in a preclinical in vivo proof-of-concept … Continue reading →

Posted in BiondVax Pharmaceuticals Ltd. BVXV | Leave a comment

Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) Carries Out Exploratory Drilling Work at Iska Iska Project; Receives Mention by Brent Cook as Showing ‘Great Potential’

Posted on November 29, 2022 by MissionIR

The discovery of Bolivia’s Potosi silver mine in 1545 was a matter of chance. Don Diego Gualpa, an Andean man recounted the tale to the Spanish viceroy taking charge of the region whilst on his deathbed; Gualpa detailed how, whilst … Continue reading →

Posted in Eloro Resources Ltd. ELRRF | Leave a comment